U-100 Versus U-500 Insulin Near-Miss
Your community pharmacy fills about 250 prescriptions daily and has two pharmacists and three technicians. A technician enters and fills a new e-prescription for 'insulin regular U-100, 10 units subcut three times daily with meals' for a patient with type 1 diabetes. The pharmacy stocks insulin regular U-100 vials and insulin regular U-500 vials because another patient uses U-500. The vials look similar, and the U-500 label is only slightly different. The technician places a U-500 vial in the bag. The pharmacist catches the error at final verification before the patient leaves. No dose was administered. The pharmacy uses barcode scanning at filling but not at final verification.
1. What immediate actions should the pharmacy take after this near-miss?
Read the worked answer
Correct the immediate risk first: remove the U-500 vial from the bag, dispense the prescribed U-100 product, and have a pharmacist independently verify the concentration, product, and dose before the patient leaves. Since no dose was administered, the patient does not need urgent medical evaluation, but the error should be disclosed appropriately and the patient counseled on the difference between U-100 and U-500. Complete an internal incident/near-miss report the same day, notify the pharmacy manager, and preserve the involved packaging. Use a just-culture approach: the goal is to learn what allowed the U-500 vial to reach final verification, not to assign individual blame.
2. Identify contributing system factors and recommend changes.
Read the worked answer
Contributing factors include look-alike vials stored near each other, high-alert insulin, barcode scanning only at filling and not at final verification, and a busy workflow. Recommend separate storage for U-500 (preferably a dedicated bin with prominent warning labels), tall-man/heightened labeling, and a hard-stop or independent double-check for all insulin. Add barcode scanning at final verification, limit U-500 stock to what is needed, and require U-500-specific syringes. Educate staff about U-100 versus U-500 and report the event through the ISMP Medication Errors Reporting Program. Audit insulin near-misses monthly and track whether the safeguards actually reduce them.
3. What counseling points are essential when dispensing insulin?
Read the worked answer
Confirm the concentration and device every time: U-100 and U-500 are not interchangeable, and U-500 must never be drawn into a U-100 syringe. Teach the patient to check the vial or pen label, use the correct syringe or pen needle, and never share pens. Review hypoglycemia symptoms, treatment, and when to call. Cover storage (unopened vials refrigerated; in-use according to manufacturer), inspection for particles or discoloration, and safe disposal. Ask the patient to repeat back the dose and concentration. Document the counseling and provide written instructions, especially when switching products or concentrations.